Stay updated on Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.

Latest updates to the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, indicating an internal update to the site's infrastructure. It does not change the study details, eligibility criteria, or outcomes.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedFooter revision label updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded Revision: v3.5.0; Removed Revision: v3.4.3.SummaryDifference0.0%

- Check60 days agoChange DetectedSite revision updated to v3.4.3, replacing the prior Revision: v3.4.2.SummaryDifference0.0%

- Check88 days agoChange DetectedFooter now displays Revision: v3.4.2 and the older government funding/operating status notices (v3.4.1) have been removed.SummaryDifference0.4%

- Check95 days agoChange DetectedNotice about a lapse in government funding and the NIH Clinical Center's operating status added; site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.